How Insulin Doses May Affect Heart Rate Rhythm in Type 1 Diabetes

Researchers enrolled adults with type 1 diabetes who use insulin therapy and monitored them continuously over four consecutive days during their normal daily routines. Participants wore devices that tracked heart rate variability (HRV)—the natural variation in time between heartbeats—and continuous glucose monitors simultaneously.

Heart rate variability is controlled by the autonomic nervous system, which has two main branches: the sympathetic nervous system (often called 'fight or flight') and the parasympathetic nervous system (often called 'rest and digest'). By analyzing the balance between these two systems using a measurement called the LF/HF ratio, researchers could assess which system was more dominant.

The study found that participants who took higher bolus insulin doses showed increased sympathetic nervous system activity (higher LF/HF ratios) during the early sleep phase. Similarly, those on higher basal insulin doses showed this pattern during the late sleep phase.

Importantly, these associations persisted even when researchers adjusted their analysis to account for average blood sugar levels and how much blood sugar fluctuated. This means the link between insulin dose and sympathetic activity appeared independent of how well blood sugar was controlled.

The sympathetic nervous system naturally activates in response to various stresses, including physical exertion and low blood sugar. While some sympathetic activation is normal and necessary, sustained predominance of sympathetic activity has been associated with cardiovascular stress.

This research suggests that insulin itself—beyond its blood sugar-lowering effects—may influence the heart's autonomic nervous system function. Understanding this relationship could be important for people with type 1 diabetes, who already face elevated cardiovascular risk compared to the general population.

This is an observational study, meaning it identified an association but did not prove that insulin dosing directly causes these changes in heart rate variability. The findings were collected during sleep phases, which may have different autonomic characteristics than waking hours.

The researchers suggest that when insulin regimens are being optimized, healthcare providers should consider cardiac autonomic balance alongside traditional targets like average blood sugar and time in range. However, they note that further research is needed to understand whether these changes in heart rate variability have meaningful long-term health effects and whether different insulin delivery methods or formulations might affect this relationship.

Source: Diabetes. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.